Clinical trials: Oedema
Edematous Fibrosclerotic Panniculopathy
Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women
This is a Phase 2b, rollover, long-term study to evaluate the safety and duration of efficacy of EN3835 in the treatment of women with EFP.
- Trial name
- NCT03893890
- Testing
- Previously Treated with EN3835
- Where
- 5 sites in United States
- Volunteers
- 8 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company